| 13F holders | Current |
|---|---|
| Total holders | 15 |
| Opened positions | 7 |
| Closed positions | 2 |
| Increased positions | 2 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 722.88 mm |
| Total shares | 14.53 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| James Peyer | 5.24 mm | $0.00 |
| H&S Investments I | 4.44 mm | $0.00 |
| Cambrian BioPharma | 3.65 mm | $4.60 mm |
| Vanguard | 618.76 k | $370.02 mm |
| Renaissance Technologies | 215.57 k | $128.91 mm |
| Geode Capital Management | 163.14 k | $97.57 mm |
| Bridgeway Capital Management | 47.90 k | $28.64 mm |
| NA.R National Bank of Canada | 45.58 k | $27.25 mm |
| NTRS Northern Trust | 25.98 k | $15.54 mm |
| STT State Street | 25.77 k | $15.41 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Jun 24 | Cambrian BioPharma | Stock Option Common Stock | Grant | Acquire A | No | No | 0.709 | 19,000 | 13.47 k | 19,000 |
